Total Payments
$1,635
2024 Payments
$869.03
Companies
20
Transactions
79
Medicare Patients
904
Medicare Billing
$152,034
Payment Breakdown by Category
Food & Beverage$1,596 (97.6%)
Education$38.68 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,596 | 77 | 97.6% |
| Education | $38.68 | 2 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $293.62 | 14 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $227.56 | 13 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $213.77 | 8 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $121.64 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $110.02 | 6 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $104.14 | 5 | $0 (2024) |
| Travere Therapeutics, Inc. | $95.04 | 5 | $0 (2024) |
| Horizon Therapeutics plc | $73.04 | 3 | $0 (2023) |
| Novo Nordisk Inc | $54.37 | 3 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $46.32 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $869.03 | 42 | Amgen Inc. ($185.92) |
| 2023 | $614.03 | 29 | Amgen Inc. ($92.70) |
| 2022 | $151.70 | 8 | Otsuka America Pharmaceutical, Inc. ($45.81) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/13/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.05 | General |
| 12/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Nephrology | ||||||
| 11/27/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: NEPHROLOGY | ||||||
| 10/14/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: NEPHROLOGY | ||||||
| 10/03/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardio-renal | ||||||
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.12 | General |
| 08/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Cardio-renal | ||||||
| 08/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.51 | General |
| 08/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Nephrology | ||||||
| 05/30/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Rare Disease | ||||||
| 05/29/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $23.76 | General |
| 05/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/11/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $23.59 | General |
| 04/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 594 | 1,085 | $263,365 | $114,734 |
| 2022 | 7 | 310 | 552 | $84,465 | $37,300 |
Total Patients
904
Total Services
1,637
Medicare Billing
$152,034
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 32 | 199 | $125,370 | $53,240 | 42.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 226 | 469 | $58,625 | $27,749 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 103 | $18,200 | $9,132 | 50.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 62 | $15,500 | $5,834 | 37.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 63 | 99 | $14,850 | $5,381 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $10,320 | $4,951 | 48.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 45 | $7,875 | $4,003 | 50.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $8,400 | $2,945 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 34 | $4,225 | $1,500 | 35.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 153 | 367 | $45,875 | $19,921 | 43.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 67 | 69 | $17,250 | $7,066 | 41.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 27 | 44 | $6,600 | $2,453 | 37.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $5,250 | $2,251 | 42.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $2,890 | $2,171 | 75.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 24 | $4,200 | $1,872 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 16 | $2,400 | $1,565 | 65.2% |
About Dr. Kyle Zoll, DO
Dr. Kyle Zoll, DO is a Nephrology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2017. The National Provider Identifier (NPI) number assigned to this provider is 1851822423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Zoll, DO has received a total of $1,635 in payments from pharmaceutical and medical device companies, with $869.03 received in 2024. These payments were reported across 79 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,596).
As a Medicare-enrolled provider, Zoll has provided services to 904 Medicare beneficiaries, totaling 1,637 services with total Medicare billing of $152,034. Data is available for 2 years (2022–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Raleigh, NC
- Active Since 03/24/2017
- Last Updated 02/12/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1851822423
Products in Payments
- JYNARQUE (Drug) $213.77
- KRYSTEXXA (Biological) $168.93
- TAVNEOS (Drug) $134.36
- Kerendia (Drug) $121.64
- FARXIGA (Drug) $110.02
- ACTHAR (Biological) $104.14
- Velphoro (Drug) $95.25
- TARPEYO (Drug) $46.32
- Aranesp (Biological) $45.05
- BENLYSTA (Biological) $44.10
- FABRAZYME (Biological) $43.60
- ULTOMIRIS (Biological) $40.15
- LUPKYNIS (Drug) $35.20
- Veltassa (Drug) $34.68
- Ozempic (Drug) $30.86
- RAYALDEE (Drug) $21.79
- Auryxia (Drug) $20.86
- JARDIANCE (Drug) $18.67
- Parsabiv (Drug) $18.32
- KEVEYIS (Drug) $16.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Raleigh
Jeffrey Hoggard, M.d, M.D
Nephrology — Payments: $100,306
Nephrology $100,306
Dr. Sammy Moghazi, M.d, M.D
Nephrology — Payments: $55,439
Nephrology $55,439
Dr. Libbie Mckenzie, Md, MD
Nephrology — Payments: $34,174
Nephrology $34,174
Karn Gupta, Md, MD
Nephrology — Payments: $11,108
Nephrology $11,108
Dr. Michael Casey, M.d, M.D
Nephrology — Payments: $8,023
Nephrology $8,023
Dr. Phillip Timmons, M.d, M.D
Nephrology — Payments: $6,018
Nephrology $6,018